Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03567343 · ClinicalTrials.gov registry record · NA
Investigational Test of a New Sleep Supplement
A NA study, sponsored by University of Arizona.
- Completed
- Registry status
- NA
- Development phase
- 105
- Enrollment target
NCT03567343: Completed NA study, sponsored by University of Arizona.
NCT03567343 is a NA study that has completed, run by University of Arizona. The registered enrollment target is 105 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03567343, a NA study, has completed, sponsored by University of Arizona.
- COMPLETED
- Registry status
- NA
- Development phase
- 105 participants
- Enrollment target
Study Summary
This study seeks to observe the effects of a proprietary spearmint extract and green tea blend on sleep quality and duration. The study observes the effect of the supplement regarding sleep quality, and mental health.
Primary Outcome
Time it takes to fall asleep after the lights have been turned off in minutes (Weekly averages)
Interventions
- OTHER Control
- DIETARY_SUPPLEMENT Proprietary Spearmint Extract Blend
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2018-05-18 |
| Est. Completion | 2019-10-15 |
| Phase | NA |
What the finished NCT03567343 record still lists
NCT03567343 is an interventional study that assigns participants to a tested intervention. The registered 105 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT03567343 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03567343 about?
NCT03567343 is a clinical study titled "Investigational Test of a New Sleep Supplement". This study seeks to observe the effects of a proprietary spearmint extract and green tea blend on sleep quality and duration. The study observes the effect of the supplement regarding sleep quality, and mental health.
What is the current status of trial NCT03567343?
This trial is currently completed. It is a NA study. The enrollment target is 105 participants. The study started on 2018-05-18. Estimated completion is 2019-10-15.
What interventions are being tested in trial NCT03567343?
The interventions under investigation include: Control (OTHER), Proprietary Spearmint Extract Blend (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03567343?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03567343's enrollment target sits among peer trials
105 834th of 2000 higher than 1,165 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03372317 · 105 participants
Tau PET in Imaging and Cognition: Healthy Adults From 55-90
- NCT04253964 · 105 participants · Phase 2
Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy
- NCT04742452 · 105 participants · NA
Comparison of Partial Rotator Cuff Repair vs. Superior Capsular Reconstruction for Irreparable Rotator Cuff Tears
- NCT04875429 · 105 participants · NA
Zenith® Fenestrated+ Clinical Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI